Microbiology

  1. Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative

    1. Sameer Kumar Malladi
    2. Unnatiben Rajeshbhai Patel
    3. Raju S. Rajmani
    4. Randhir Singh
    5. Suman Pandey
    6. Sahil Kumar
    7. Sara Khaleeq
    8. Petrus Jansen van Vuren
    9. Shane Riddell
    10. Sarah Goldie
    11. Savitha Gayathri
    12. Debajyoti Chakraborty
    13. Parismita Kalita
    14. Ishika Pramanick
    15. Nupur Agarwal
    16. Poorvi Reddy
    17. Nidhi Girish
    18. Aditya Upadhyaya
    19. Mohammad Suhail Khan
    20. Kawkab Kanjo
    21. Madhuraj Bhat
    22. Shailendra Mani
    23. Sankar Bhattacharyya
    24. Samreen Siddiqui
    25. Akansha Tyagi
    26. Sujeet Jha
    27. Rajesh Pandey
    28. Shashank Tripathi
    29. Somnath Dutta
    30. Alexander J. McAuley
    31. Nagendrakumar Balasubramanian Singanallur
    32. Seshadri S. Vasan
    33. Rajesh P. Ringe
    34. Raghavan Varadarajan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Potent SARS-CoV-2 neutralizing antibodies selected from a human antibody library constructed decades ago

    1. Min Qiang
    2. Peixiang Ma
    3. Yu Li
    4. Hejun Liu
    5. Adam Harding
    6. Chenyu Min
    7. Lili Liu
    8. Meng Yuan
    9. Qun Ji
    10. Pingdong Tao
    11. Xiaojie Shi
    12. Zhean Li
    13. Fulian Wang
    14. Yu Zhang
    15. Nicholas C. Wu
    16. Chang-Chun D. Lee
    17. Xueyong Zhu
    18. Javier Gilbert-Jaramillo
    19. Abhishek Saxena
    20. Xingxu Huang
    21. Hou Wang
    22. William James
    23. Raymond A. Dwek
    24. Ian A. Wilson
    25. Guang Yang
    26. Richard A. Lerner

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate

    1. Devanshi R. Patel
    2. Cassandra J. Field
    3. Kayla M. Septer
    4. Derek G. Sim
    5. Matthew J. Jones
    6. Talia A. Heinly
    7. Thomas H. Vanderford
    8. Elizabeth A. McGraw
    9. Troy C. Sutton

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine

    1. Yasunori Watanabe
    2. Luiza Mendonça
    3. Elizabeth R. Allen
    4. Andrew Howe
    5. Mercede Lee
    6. Joel D. Allen
    7. Himanshi Chawla
    8. David Pulido
    9. Francesca Donnellan
    10. Hannah Davies
    11. Marta Ulaszewska
    12. Sandra Belij-Rammerstorfer
    13. Susan Morris
    14. Anna-Sophia Krebs
    15. Wanwisa Dejnirattisai
    16. Juthathip Mongkolsapaya
    17. Piyada Supasa
    18. Gavin R. Screaton
    19. Catherine M. Green
    20. Teresa Lambe
    21. Peijun Zhang
    22. Sarah C. Gilbert
    23. Max Crispin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure

    1. Emma K. Loveday
    2. Kyle S. Hain
    3. Irina Kochetkova
    4. Jodi F. Hedges
    5. Amanda Robison
    6. Deann T. Snyder
    7. Susan K. Brumfield
    8. Mark J. Young
    9. Mark A. Jutila
    10. Connie B. Chang
    11. Matthew P. Taylor

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. SARS-CoV-2 Envelope (E) protein interacts with PDZ-domain-2 of host tight junction protein ZO1

    1. Ariel Shepley-McTaggart
    2. Cari A. Sagum
    3. Isabela Oliva
    4. Elizabeth Rybakovsky
    5. Katie DiGuilio
    6. Jingjing Liang
    7. Mark T. Bedford
    8. Joel Cassel
    9. Marius Sudol
    10. James M. Mullin
    11. Ronald N. Harty

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Oral Delivery of SARS-CoV-2 DNA Vaccines Using Attenuated Salmonella typhimurium as a Carrier in Rat

    1. Dan Zhu
    2. Mengyue Mengyue
    3. Aaodeng Qimuge
    4. Bilige Bilige
    5. Tegexi Baiyin
    6. Temuqile Temuqile
    7. Shana Chen
    8. Siqin Borjigen
    9. Huricha Baigude
    10. Dezhi Yang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. A comparative analysis of SARS-CoV-2 antivirals in human airway models characterizes 3CL pro inhibitor PF-00835231 as a potential new treatment for COVID-19

    1. Maren de Vries
    2. Adil S Mohamed
    3. Rachel A Prescott
    4. Ana M Valero-Jimenez
    5. Ludovic Desvignes
    6. Rebecca O’Connor
    7. Claire Steppan
    8. Joseph C Devlin
    9. Ellie Ivanova
    10. Alberto Herrera
    11. Austin Schinlever
    12. Paige Loose
    13. Kelly Ruggles
    14. Sergei B Koralov
    15. Annaliesa S. Anderson
    16. Joseph Binder
    17. Meike Dittmann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. The Preclinical Inhibitor GS441524 in Combination with GC376 Efficaciously Inhibited the Proliferation of SARS-CoV-2 in the Mouse Respiratory Tract

    1. Yuejun Shi
    2. Lei Shuai
    3. Zhiyuan Wen
    4. Chong Wang
    5. Yuanyuan Yan
    6. Zhe Jiao
    7. Fenglin Guo
    8. Zhen F. Fu
    9. Huanchun Chen
    10. Zhigao Bu
    11. Guiqing Peng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Potent mouse monoclonal antibodies that block SARS-CoV-2 infection

    1. Youjia Guo
    2. Atsushi Kawaguchi
    3. Masaru Takeshita
    4. Takeshi Sekiya
    5. Mikako Hirohama
    6. Akio Yamashita
    7. Haruhiko Siomi
    8. Kensaku Murano

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 160 of 247 Next